Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy

被引:303
作者
Rubinshtein, Ronen [1 ]
Glockner, James F. [2 ]
Ommen, Steve R. [1 ]
Araoz, Philip A. [2 ]
Ackerman, Michael J. [1 ,3 ,4 ,5 ]
Sorajja, Paul [1 ]
Bos, J. Martijn [5 ]
Tajik, A. Jamil [6 ]
Valeti, Uma S. [1 ]
Nishimura, Rick A. [1 ]
Gersh, Bernard J. [1 ]
机构
[1] Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Pediat, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
[5] Mayo Clin, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN 55905 USA
[6] Mayo Clin, Div Cardiovasc Dis, Scottsdale, AZ USA
关键词
hypertrophic cardiomyopathy; magnetic resonance imaging; late gadolinium enhancement; sudden death and risk assessment; SURGICAL SEPTAL MYECTOMY; SUDDEN CARDIAC DEATH; DELAYED ENHANCEMENT; RISK; YOUNG; DEFIBRILLATORS; SYMPTOMS; FIBROSIS; ABLATION;
D O I
10.1161/CIRCHEARTFAILURE.109.854026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Myocardial late gadolinium enhancement (LGE) on contrast-enhanced magnetic resonance imaging (CE-MRI) of patients with hypertrophic cardiomyopathy (HCM) has been suggested to represent intramyocardial fibrosis and, as such, an adverse prognostic risk factor. We evaluated the characteristics of LGE on CE-MRI and explored whether LGE among patients with HCM was associated with genetic testing, severe symptoms, ventricular arrhythmias, or sudden cardiac death (SCD). Methods and Results-Four hundred twenty-four patients with HCM (age=55+/-16 years [range 2 to 90], 41% females), without a history of septal ablation/myectomy, underwent CE-MRI (GE 1.5 Tesla). We evaluated the relation between LGE and HCM genes status, severity of symptoms, and the degree of ventricular ectopy on Holter ECG. Subsequent SCD and appropriate implanted cardioverter defibrillator (ICD) therapies were recorded during a mean follow-up of 43+/-14 months (range 16 to 94). Two hundred thirty-nine patients (56%) had LGE on CE-MRI, ranging from 0.4% to 65% of the left ventricle. Gene-positive patients were more likely to have LGE (P<0.001). The frequencies of New York Heart Association class >= 3 dyspnea and angina class >= 3 were similar in patients with and without LGE (125 of 239 [52%] versus 94 of 185 [51%] and 24 of 239 [10%] versus 18 of 185 [10%], respectively, P=NS). LGE-positive patients were more likely to have episodes of nonsustained ventricular tachycardia (34 of 126 [27%] versus 8 of 94 [8.5%], P<0.001), had more episodes of nonsustained ventricular tachycardia per patient (4.5+/-12 versus 1.1+/-0.3, P=0.04), and had higher frequency of ventricular extrasystoles/24 hours (700+/-2080 versus 103+/-460, P=0.003). During follow-up, SCD occurred in 4 patients, and additional 4 patients received appropriate ICD discharges. All 8 patients were LGE positive (event rate of 0.94%/y, P=0.01 versus LGE negative). Two additional heart failure-related deaths were recorded among LGE-positive patients. Univariate associates of SCD or appropriate ICD discharge were positive LGE (P=0.002) and presence of nonsustained ventricular tachycardia (P=0.04). The association of LGE with events remained significant after controlling for other risk factors. Conclusions-In patients with HCM, presence of LGE on CE-MRI was common and more prevalent among gene-positive patients. LGE was not associated with severe symptoms. However, LGE was strongly associated with surrogates of arrhythmia and remained a significant associate of subsequent SCD and/or ICD discharge after controlling for other variables. If replicated, LGE may be considered an important risk factor for sudden death in patients with HCM. (Circ Heart Fail. 2010; 3: 51-58.)
引用
收藏
页码:51 / 58
页数:8
相关论文
共 39 条
[1]   Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy on relation to delayed enhancement on cardiovascular magnetic resonance [J].
Adabag, A. Selcuk ;
Maron, Barry J. ;
Appelbaum, Evan ;
Harrigan, Caltlin J. ;
Buros, Jacqueline L. ;
Gibson, C. Michael ;
Lesser, John R. ;
Hanna, Constance A. ;
Udelson, James E. ;
Manning, Warren J. ;
Maron, Martin S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (14) :1369-1374
[2]   Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy [J].
Assomull, Ravi G. ;
Prasad, Sanjay K. ;
Lyne, Jonathan ;
Smith, Gillian ;
Burman, Elizabeth D. ;
Khan, Mohammed ;
Sheppard, Mary N. ;
Poole-Wilson, Philip A. ;
Pennell, Dudley J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (10) :1977-1985
[3]   The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms [J].
Autore, C ;
Bernabò, P ;
Barillà, CS ;
Bruzzi, P ;
Spirito, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (07) :1076-1080
[4]   Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia [J].
Basso, C ;
Thiene, G ;
Corrado, D ;
Buja, G ;
Melacini, P ;
Nava, A .
HUMAN PATHOLOGY, 2000, 31 (08) :988-998
[5]   Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: Septal morphological features predict the presence of myofilament mutations [J].
Binder, J ;
Ommen, SR ;
Gersh, BJ ;
Van Driest, SL ;
Tajik, AJ ;
Nishimura, RA ;
Ackerman, MJ .
MAYO CLINIC PROCEEDINGS, 2006, 81 (04) :459-467
[6]   Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy [J].
Bos, J. Martijn ;
Theis, Jeanne L. ;
Tajik, A. Jamil ;
Gersh, Bernard J. ;
Ommen, Steve R. ;
Ackernian, Michael J. .
AMERICAN HEART JOURNAL, 2008, 155 (06) :1128-1134
[7]   NATURAL-HISTORY OF HYPERTROPHIC CARDIOMYOPATHY - A POPULATION-BASED STUDY, 1976 THROUGH 1990 [J].
CANNAN, CR ;
REEDER, GS ;
BAILEY, KR ;
MELTON, LJ ;
GERSH, BJ .
CIRCULATION, 1995, 92 (09) :2488-2495
[8]   Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy [J].
Choudhury, L ;
Mahrholdt, H ;
Wagner, A ;
Choi, KM ;
Elliott, MD ;
Klocke, FJ ;
Bonow, RO ;
Judd, RM ;
Kim, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (12) :2156-2164
[9]   Surgery insight: septal myectomy for obstructive hypertrophic cardiomyopathy - the Mayo Clinic experience [J].
Dearani, Joseph A. ;
Ommen, Steve R. ;
Gersh, Bernard J. ;
Schaff, Hartzell V. ;
Danielson, Gordon K. .
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (09) :503-512
[10]   Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients [J].
Elliott, PM ;
Poloniecki, J ;
Dickie, S ;
Sharma, S ;
Monserrat, L ;
Varnava, A ;
Mahon, NG ;
McKenna, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2212-2218